Work

Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612)

Year: 2015

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-015-2828-2

Authors: Robert A. Parise, Julie L. Eiseman, Dana M. Clausen, Kimberly P. Kicielinski, Pamela A. Hershberger, Merrill J. Egorin, Jan H. Beumer

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, Roswell Park Comprehensive Cancer Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1529121756, Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis, Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents, G422284981, G424558205, G5032682418, G741073515, G8051694844, NCI ETCTN Pittsburgh Cancer Consortium (PCC)

OpenAlex ID: W2184732808

FWCI:

Cites: 28

Cited by: 4

Related to: 10